Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ENvue Medical (FEED) Return on Sales (2017 - 2025)

Historic Return on Sales for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to 0.71%.

  • ENvue Medical's Return on Sales rose 33600.0% to 0.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 13000.0%. This contributed to the annual value of 1.47% for FY2024, which is 1800.0% down from last year.
  • As of Q3 2025, ENvue Medical's Return on Sales stood at 0.71%, which was up 33600.0% from 8.04% recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Return on Sales registered a high of 33.69% during Q4 2021, and its lowest value of 54513.27% during Q4 2022.
  • Its 5-year average for Return on Sales is 2871.64%, with a median of 2.65% in 2024.
  • In the last 5 years, ENvue Medical's Return on Sales tumbled by -545469600bps in 2022 and then skyrocketed by 545189300bps in 2023.
  • ENvue Medical's Return on Sales (Quarter) stood at 33.69% in 2021, then plummeted by -161913bps to 54513.27% in 2022, then surged by 100bps to 5.65% in 2023, then soared by 140bps to 13.58% in 2024, then crashed by -95bps to 0.71% in 2025.
  • Its Return on Sales stands at 0.71% for Q3 2025, versus 8.04% for Q2 2025 and 2.43% for Q1 2025.